Showing results (41-50 of 556) with videos related to
Sort By:
Pageof 56
South Asian Journal of Cancer|February 16, 2019
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line - Indian consensus statement updateKumar PrabhashOral Oncology|September 24, 2021
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trialNandini Menon, Vijay Patil, Vanita Noronha, et al.Ecancermedicalscience|September 8, 2022
ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenarioAjaykumar Singh, Akhil Kapoor, Vanita Noronha, et al.South Asian Journal of Cancer|January 21, 2020
Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancerVanita Noronha, Nikhil Pande, Amit Joshi, et al.Lung Cancer (Auckland, N.Z.)|February 19, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisShruti Kate, Anuradha Chougule, Amit Joshi, et al.South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.BMJ Open|February 16, 2021
Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancerAnil Tibdewal, JaiPrakash Agarwal, Naveen Mummudi, et al.Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.Ecancermedicalscience|March 28, 2019
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomesAmit Joshi, Nikhil Pande, Vanita Noronha, et al.Chemotherapy Research and Practice|December 31, 2014
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC PatientsVanita Noronha, Amit Joshi, Anant Gokarn, et al.Pageof 56